A new study has discovered that stem cells in bone marrow need to produce hydrogen sulfide in order to properly multiply and form bone tissue. The presence of hydrogen sulfide produced by the cells governs the flow of calcium ions, which activates a chain of cellular signals that results in osteogenesis, or the creation of new bone tissue, and keeps the breakdown of old bone tissue at a proper level.
The Japanese scientist accused of falsifying data...
Researchers have reported they can generate human...
Stem cells have the potential to repair human...
A new organ has been developed at George Washington Univ. to help return blood flow from veins lacking functional valves. A rhythmically contracting cuff made of cardiac muscle cells surrounds the vein acting as a 'mini heart' to aid blood flow through venous segments. The cuff can be made of a patient’s own adult stem cells, eliminating the chance of implant rejection.
In 2007, Massachusetts Institute of Technology scientists developed a type of microscopy that allowed them to detail the interior of a living cell in 3-D, without adding any fluorescent markers or other labels. This technique also revealed key properties, such as the cells’ density. Now the researchers have adapted that method so they can image cells as they flow through a tiny microfluidic channel.
Overcoming a major limitation to the study of the origins and progress of human disease, Yale Univ. researchers report that they have transplanted human innate immune cells into mouse models, which resulted in human immune responses. This study has reproduced human immune function at a level not seen previously, and could significantly improve the translation of knowledge gained from mouse studies into humans.
The Riken Center for Development Biology in Kobe, Japan, has been looking into questions raised over images and wording in a research paper describing a simple way of turning ordinary cells from mice into stem cells. Riken said Tuesday that it may retract the paper because of credibility and ethics issues, even though an investigation is continuing.
In end-stage lung disease, transplantation is sometimes the only viable therapeutic option, but organ availability is limited and rejection presents an additional challenge. New methods and techniques in the field of tissue regeneration hold promise for this population, which includes an estimated 12.7 million people with chronic obstructive pulmonary disorder (COPD).
Typically, researchers construct cell-building scaffolds from synthetic materials or natural animal or human substances. Until now, however, no scaffolds grown in a Petri dish have been able to mimic the highly organized structure of the matrix made by living things. Researchers in Michigan have used a nano-grate to persuade fibroblasts to grow a scaffold with fibers just 80 nm, similar to to fibers in a natural matrix.
In the battle against infection, immune cells are the body's offense and defense. It has long been known that a population of blood stem cells that resides in the bone marrow generates all of these immune cells. But most scientists have believed that blood stem cells participate in battles against infection in a delayed way, replenishing immune cells on the front line only after they become depleted.
Univ. of California, Berkeley researchers have shown that chronic stress generates long-term changes in the brain that may explain why people suffering chronic stress are prone to mental problems such as anxiety and mood disorders later in life. Their findings could lead to new therapies to reduce the risk of developing mental illness after stressful events.
A one-letter change in the human genetic code can sometimes mean the difference between health and a serious disease. But replicating these tiny changes in human stem cells has proven challenging. Scientists at the Gladstone Institutes have found a way to efficiently edit the human genome one letter at a time, not only boosting researchers' ability to model human disease, but also paving the way for new therapies.
Stem cell research has been breaking ground in new application areas over the past few years, and it’s poised for even greater growth as more companies and organizations realize the potential. In the next decade, cell-based therapies will become increasingly common for cancer, immunological disorders, cardiac failure and other conditions.
The Salk Institute for Biological Studies will join Stanford Univ. in leading a new Center of Excellence in Stem Cell Genomics, created through a $40 million award by California's stem cell agency. The center will bring together experts and investigators from seven major California institutions to focus on bridging the fields of genomics with cutting-edge stem cell research and ultimately find new therapies.
A fundamental axiom of biology used to be that cell fate is a one-way street—once a cell commits to becoming muscle, skin or blood it always remains muscle, skin or blood cell. That belief was upended in the past decade when a Japanese scientist introduced four simple factors into skin cells and returned them to an embryonic-like state, capable of becoming of almost any cell type in the body.
Univ. of Oregon biologists say they have opened the window on the natural process of bone regeneration in zebra fish, and that the insights they gained could be used to advance therapies for bone fractures and disease. Their work shows that two molecular pathways work in concert to allow adult zebra fish to perfectly replace bones lost upon fin amputation.
Scientists in Japan have developed a new, surprisingly simple method for creating stem cell. In a pair of reports, the researchers show that ordinary somatic cells from newborn mice can be stripped of their differentiation memory, reverting to a state of pluripotency resembling embryonic stem cells and induced pluripotent stem cells. All that’s needed is a dose of sublethal stress.
A new method allows for large-scale generation of human embryonic stem cells of high clinical quality. It also allows for production of such cells without destroying any human embryos. The discovery is a big step forward for stem cell research and for the high hopes for replacing damaged cells and thereby curing serious illnesses such as diabetes and Parkinson's disease.
HIV antiviral therapy lets infected people live relatively healthy lives for many years, but the virus doesn’t go away completely. If treatment stops, the virus multiplies again from hidden reservoirs in the body. Now, investigators from the Massachusetts General Hospital and the Ragon Institute may have found HIV’s viral hiding place—in a small group of recently identified T-cells with stem cell-like properties.
A team of engineers at the Univ. of Wisconsin-Madison has created a process to improve the creation of synthetic neural stem cells for use in central nervous system research. The process, outlined in a paper published in Stem Cells, will improve the state of the art in the creation of synthetic neural stem cells for use in central nervous system research.
A new porous structure under development in German possesses essential properties of natural bone marrow and can be used for the reproduction of stem cells in the laboratory. The specific reproduction of these hematopoietic cells outside the body might facilitate new therapies for leukemia in a few years.
Harvard Univ. stem cells scientists at Brigham and Women’s Hospital and Massachusetts Institute of Technology can now engineer cells that are more easily controlled following transplantation, potentially making cell therapies, hundreds of which are currently in clinical trials across the U.S., more functional and efficient.
In the 2nd century BC, Indian surgeon Sushruta used autografted skin transplantation in nose reconstruction, also known as rhinoplasty. This was the first reasonable account of organ transplantation recorded. The first successful human corneal transplant was performed in 1905 in the Czech Republic, and the first steps to skin transplantation occurred during World War I. The first successful kidney transplant happened in 1962 in the U.S.
With the help of biomimetic matrices, a research team led by bioengineers at the Univ. of California, San Diego has discovered exactly how calcium phosphate can coax stem cells to become bone-building cells. The team has traced a surprising pathway from these biomaterials to bone formation. Their findings will help them refine the design of biomaterials that encourage stem cells to give rise to new bone.
The blood stem cells that live in bone marrow are at the top of a complex family tree. Such stem cells split and divide down various pathways that ultimately produce red cells, white cells and platelets. These “daughter” cells must be produced at a rate of about one million per second to constantly replenish the body’s blood supply. Researchers have long wondered what allows these stem cells to persist for decades, until now.
Diseases affecting the kidneys represent a major and unsolved health issue worldwide. The kidneys rarely recover function once they are damaged by disease, highlighting the urgent need for better knowledge of kidney development and physiology. Now, a team of researchers has developed a novel platform to study kidney diseases, opening new avenues for the future application of regenerative medicine strategies to help restore kidney function.
Officials at the University of California, San Diego announced that philanthropist T. Denny Sanford has committed $100 million to the creation of the Sanford Stem Cell Clinical Center. The center is intended to accelerate development of drugs and therapies derived from human stem cell research through clinical trials and patient therapies.
Bioengineers at the Univ. of California, Berkeley have shown that physical cues can replace certain chemicals when nudging mature cells back to a pluripotent stage, capable of becoming any cell type in the body. The researchers grew fibroblasts on surfaces with parallel grooves measuring 10 µm wide and 3 µm high.
- Page 1